(ii) Conversely, reduced SETD8 expression is associated with a better survival rate in multiple cancer types, including small‐cell lung cancer, ovarian cancer, hepatocellular carcinoma, and breast cancer (Milite et al., 2016). This evidence concerns the gene KMT5A and cancer.